Related Experiment Video
Updated: May 22, 2025
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
IER3: exploring its dual function as an oncogene and tumor suppressor
Meena Kanduri1, Santhilal Subhash2,3,4, Rossana Putino5
1Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Meena.kanduri@gu.se.
Abstract:
The IER3 gene has a complex role in cancer biology, acting either as a tumor suppressor or an oncogene, depending on the cancer type. This duality underscores the complexity and importance of molecular pathways in modulating cancer behavior. Despite its significance in cancer development, there is a dearth of studies elucidating the exact mechanisms underlying IER3's involvement in modulating cancer behavior. Here, utilizing cervical carcinoma and neuroblastoma (NB) cell lines as model systems we characterized the pathways that mediate the functional switch between the oncogenic and tumor suppressor roles of IER3. In HeLa cells, IER3 expression promotes an oncogenic program that includes immediate early response pathway genes such as EGR2, FOS, and JUN. However, in NB cells, IER3 suppresses the EGR2-dependent oncogenic program. This differential regulation of EGR2 by IER3 involves epigenetic modulation of the EGR2 promoter. IER3 dependent tumor suppressor pathway in NB cells relies on ADAM19 gene. Thus, our findings uncover the molecular pathways that dictate the context-dependent roles of IER3 in cancer, providing insights into its dual functionality in different cancer types.
Insights
The IER3 gene acts as both a tumor suppressor and oncogene in cancer. This study reveals molecular pathways, including epigenetic regulation of EGR2, that explain IER3
Area of Science:
- Cancer Biology
- Molecular Oncology
- Gene Regulation
Background:
- The IER3 gene exhibits dual roles in cancer, functioning as either a tumor suppressor or an oncogene, contingent on the specific cancer type.
- The precise mechanisms governing IER3's context-dependent functions in cancer progression remain incompletely understood.
- Elucidating these mechanisms is crucial for understanding cancer development and identifying therapeutic targets.
Purpose of the Study:
- To investigate the molecular pathways mediating the switch between IER3's oncogenic and tumor suppressor functions.
- To characterize the differential regulation of IER3 in cervical carcinoma and neuroblastoma cell lines.
- To identify key genes and epigenetic mechanisms involved in IER3's dual roles.
Main Methods:
- Utilized cervical carcinoma (HeLa) and neuroblastoma (NB) cell lines as model systems.
- Analyzed gene expression patterns, focusing on immediate early response pathway genes like EGR2, FOS, and JUN.
- Investigated epigenetic modulation of the EGR2 promoter.
- Examined the role of the ADAM19 gene in IER3-mediated tumor suppression.
Main Results:
- In HeLa cells, IER3 expression promoted an oncogenic program involving EGR2, FOS, and JUN.
- In NB cells, IER3 suppressed the EGR2-dependent oncogenic program.
- Epigenetic modulation of the EGR2 promoter was identified as a key mechanism for differential EGR2 regulation by IER3.
- The ADAM19 gene was found to be critical for the tumor suppressor function of IER3 in NB cells.
Conclusions:
- The study uncovers the molecular pathways dictating the context-dependent roles of IER3 in cancer.
- Findings provide insights into the dual functionality of IER3, highlighting epigenetic regulation and specific gene interactions (EGR2, ADAM19).
- This research contributes to a deeper understanding of cancer biology and the intricate mechanisms of gene regulation in disease.
Related Concept Videos
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:23Abnormal Proliferation
02:38Mitogens and the Cell Cycle
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...